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• Title: Exosuit-induced improvements in walking after stroke: comprehensive analysis on gait 
energetics and biomechanics 
• Background & Purpose: Walking after 
stroke is characterized by slow, asymmetric, 
and inefficient gait. A major contributor to 
walking deficits after stroke is impaired 
paretic ankle function. During pre-swing 
phase, impaired paretic ankle plantarflexion 
reduces the paretic limb’s contribution to 
forward propulsion. During swing phase, 
impaired paretic ankle dorsiflexion inhibits 
ground clearance by the paretic limb. Our 
laboratory developed a lightweight, soft 
wearable robot (an exosuit) that interfaces 
with the paretic limb via functional textiles to 
actively assist ankle plantarflexion (PF) and dorsiflexion (DF) during walking. The objective of this study 
was to evaluate how exosuit assistance influences poststroke gait energetics and mechanics. 
• Subjects: Seven individuals in the chronic phase of stroke recovery (Age: 49±4 y; Time poststroke: 
4.38±1.37 y; 3 females; 4 left hemiparetic) 
• Methods: Participants completed two 8-minute treadmill walking bouts at speeds comparable to their 
usual overground walking speeds. During the first bout, the exosuit was unpowered and did not provide 
assistance. During the second bout, the exosuit was powered on and provided PF and DF assistance 
during walking. Net metabolic power, body center of mass (COM) power, and ankle joint power were 
calculated based on biomechanical and energetic data. Average COM power and ankle joint power 
generated from each limb during the step-to-step transition were calculated because this period is 
important in determining metabolic power expenditure. Circumduction and hip hiking were also 
measured using motion capture. Symmetry indices (SIs) were calculated as 𝑆𝐼 = 2 ∙ &'()&(&'(*&( ∙ 100(%), 
where 	𝑋23 is the nonparetic variable and 𝑋3  is the paretic variable. Zero percent indicates perfect 
symmetry. 
• Results: When walking with the exosuit powered, participants spent 10.43±1.48% less net metabolic 
power compared to walking with the exosuit unpowered (unpowered: 4.18±0.43W/kg, powered: 
3.72±0.34W/kg, P = 0.005). Also observed were: increased inter-limb symmetry of the body COM 
power (SIunpowered=56.35±15.48%, SIpowered=33.99±10.47%, P=0.012) and ankle power generated 
during the step-to-step transition (SIunpowered=66.74±18.69%, SIpowered=54.50±17.35%, P=0.026), as well 
as 20±5% less circumduction (unpowered: 4.83±0.71 cm, powered: 3.88±0.74 cm, P=0.004) and 
27±6% less hip hiking (unpowered: 3.65±0.77cm, powered: 2.72±0.64cm, P=0.004). 
• Conclusions: Exosuit assistance during gait can reduce the metabolic requirements of hemiparetic 
walking and contribute to more symmetric body COM power and ankle power generation during the 
step-to-step transition and a reduction in compensatory gait patterns. 
• Clinical Relevance: The present findings will guide future development of gait-assisting wearable 
robots for clinical use. 
